APP and Alzheimer disease: Apparently, any factor affecting Gly29-x-x-x-Gly33 dimerization, including lipid composition, elevated cholesterol, oxidative stress, or AD-associated mutations in PSEN1 and APP, may influence the site at which γ-secretase leaves the substrate and the variability of Aβ populations [267].